Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer
NCT06144762
Summary
Specifically, in this project, the objective will be developped a model to capture imaging-based tumor heterogeneity with multiscale radiomics approach by obtaining the mirror tumor image at in vivo MRI, ex vivo MRI at histology. This imaging model giving a perfect virtual histology tumor representation will be secondary implemented on routine in vivo clinical MRI for early cancer detection and treatment monitoring. Successful completion of this proposal will lead to a comprehensive non invasive characterisation of pancreatic cancer and will be a game changer in patient management.
Eligibility
Inclusion Criteria: * Patient aged \>18 2. * Pathologically proven pancreatic cancer which can beneficiate of upfront surgery or delayed surgery followed by neoadjuvant chemotherapy. * Negative pregnancy test for women of childbearing potential * Patients affiliated to a social protection system * Written informed consent signed before project onset. Exclusion Criteria: * presence of metastases, * Patient who will not have surgery * Pregnant or breastfeeding women * Mental or psychological state, physical or legal incapacity preventing participation in the project.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06144762